Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    "nephrogenic diabetes insipidus"
Show Display Options
Rank Status Study
1 Completed Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Condition: Nephrogenic Diabetes Insipidus
Interventions: Drug: sildenafil;   Drug: calcitonin;   Drug: hydrochlorothiazide/amiloride;   Drug: indomethacin;   Drug: Placebo for sildenafil;   Drug: placebo for calcitonin
2 Recruiting Metformin and Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus
Intervention: Drug: Metformin
3 Not yet recruiting Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus
Condition: Bipolar Disorder
Interventions: Drug: Atorvastatin;   Other: placebo
4 Completed Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).
Condition: Chronic Heart Failure
Intervention: Drug: Vasopressin V2 Receptor Antagonist
5 Completed Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus, Nephrogenic
Intervention: Drug: chlorothiazide
6 Completed DILIPO (DILutIonal HyPOnatremia)
Condition: Congestive Heart Failure
Intervention: Drug: SR121463B

Study has passed its completion date and status has not been verified in more than two years.